![Tobias Bexte: Our work on the non-viral Sleeping Beauty generation of primary CAR NK cells has been recognized with a Best Paper Award by German Society for Gene and Cell Therapy](https://oncodaily.com/pub/uploads/2024/09/RljG5Qcj_400x400-e1725420755192.png)
Tobias Bexte: Our work on the non-viral Sleeping Beauty generation of primary CAR NK cells has been recognized with a Best Paper Award by German Society for Gene and Cell Therapy
Tobias Bexte, Clinician Scientist at Goethe University Frankfurt, shared a post by German Society for Gene and Cell Therapy on X, adding the following:
“I am truly honored that our work on the non-viral Sleeping Beauty generation of primary CAR NKcells has been recognized with a Best Paper Award by German Society for Gene and Cell Therapy. A heartfelt thank you to all co-authors and collaborators!”
Quoting German Society for Gene and Cell Therapy’s post:
“Congratulations! The German Society for Gene and Cell Therapy proudly awards Tobias Bexte representing the Ullrich Lab at Goethe University Frankfurt the PoQ2024Q2 for harnessing SB-technology for virus-free engineering of primary NK cells to improve their basal anti-cancer function via CAR introduction.”
Authors: Tobias Bexte, Lacramioara Botezatu, Csaba Miskey, Fenja Gierschek, Alina Moter, Philipp Wendel, Lisa Marie Reindl, Julia Campe, Jose Francisco Villena-Ossa, Veronika Gebel, Katja Stein, Toni Cathomen, Anjali Cremer, Winfried S. Wels, Michael Hudecek, Zoltán Ivics, Evelyn Ullrich
Read further.
Source: Tobias Bexte/X and German Society for Gene and Cell Therapy/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023